|
William Jr, William N; Papadimitrakopoulou, Vassiliki; Lee, J Jack et al. (2016) Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol 2:209-16
|
|
Aristizabal, Paula; Singer, Jenelle; Cooper, Renee et al. (2015) Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities. Pediatr Blood Cancer 62:1337-44
|
|
Wan, Y; Datta, S; Conklin, D J et al. (2015) Variable selection models based on multiple imputation with an application for predicting median effective dose and maximum effect. J Stat Comput Simul 85:1902-1916
|
|
Mak, Milena P; William Jr, William N (2014) Targeting the epidermal growth factor receptor for head and neck cancer chemoprevention. Oral Oncol 50:918-23
|
|
William Jr, William N; Papadimitrakopoulou, Vassiliki A (2013) Optimizing biomarkers and endpoints in oral cancer chemoprevention trials. Cancer Prev Res (Phila) 6:375-8
|
|
William Jr, William N (2012) Oral premalignant lesions: any progress with systemic therapies? Curr Opin Oncol 24:205-10
|
|
Saintigny, Pierre; Zhang, Li; Fan, You-Hong et al. (2011) Gene expression profiling predicts the development of oral cancer. Cancer Prev Res (Phila) 4:218-29
|
|
Diao, Lixia; Clarke, Charlotte H; Coombes, Kevin R et al. (2011) Reproducibility of SELDI Spectra Across Time and Laboratories. Cancer Inform 10:45-64
|
|
Lee, J Jack; Wu, Xifeng; Hildebrandt, Michelle A T et al. (2011) Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients. Cancer Prev Res (Phila) 4:185-93
|
|
Boyle, Jay O; Gumus, Zeynep H; Kacker, Ashutosh et al. (2010) Effects of cigarette smoke on the human oral mucosal transcriptome. Cancer Prev Res (Phila) 3:266-78
|
Showing the most recent 10 out of 54 publications
